Citation: Qp. Yao et al., Gene transfer of p53 to arthritic joints stimulates synovial apoptosis andinhibits inflammation, MOL THER, 3(6), 2001, pp. 901-910
Citation: Ea. Burton et Jc. Glorioso, Multi-modal combination gene therapy for malignant glioma using replication-defective HSV vectors, DRUG DISC T, 6(7), 2001, pp. 347-356
Citation: Ma. Kay et al., Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics, NAT MED, 7(1), 2001, pp. 33-40
Authors:
Poliani, PL
Brok, H
Furlan, R
Ruffini, F
Bergami, A
Desina, G
Marconi, PC
Rovaris, M
Uccelli, A
Glorioso, JC
Penna, G
Adorini, L
Comi, G
't Hart, B
Martino, G
Citation: Pl. Poliani et al., Delivery to the central nervous system of a nonreplicative herpes simplex type 1 vector engineered with the interleukin 4 gene protects rhesus monkeys from hyperacute autoimmune encephalomyelitis, HUM GENE TH, 12(8), 2001, pp. 905-920
Authors:
Goss, JR
Mata, M
Goins, WF
Wu, HH
Glorioso, JC
Fink, DJ
Citation: Jr. Goss et al., Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal roof ganglion, GENE THER, 8(7), 2001, pp. 551-556
Authors:
Ruffini, F
Furlan, R
Poliani, PL
Brambilla, E
Marconi, PC
Bergami, A
Desina, G
Glorioso, JC
Comi, G
Martino, G
Citation: F. Ruffini et al., Fibroblast growth factor-II gene therapy reverts the clinical course and the pathological signs of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice, GENE THER, 8(16), 2001, pp. 1207-1213
Authors:
Furlan, R
Poliani, PL
Marconi, PC
Bergami, A
Ruffini, F
Adorini, L
Glorioso, JC
Comi, G
Martino, G
Citation: R. Furlan et al., Central nervous system gene therapy with interleukin-4 inhibits progression of ongoing relapsing-remitting autoimmune encephalomyelitis in Biozzi AB/H mice, GENE THER, 8(1), 2001, pp. 13-19
Authors:
Mardberg, K
Trybala, E
Glorioso, JC
Bergstrom, T
Citation: K. Mardberg et al., Mutational analysis of the major heparan sulfate-binding domain of herpes simplex virus type 1 glycoprotein C, J GEN VIROL, 82, 2001, pp. 1941-1950
Authors:
Niranjan, A
Moriuchi, S
Lunsford, LD
Kondziolka, D
Flickinger, JC
Fellows, W
Rajendiran, S
Tamura, M
Cohen, JB
Glorioso, JC
Citation: A. Niranjan et al., Effective treatment of experimental glioblastoma by HSV vector-mediated TNF alpha and HSV-tk gene transfer in combination with radiosurgery and ganciclovir administration, MOL THER, 2(2), 2000, pp. 114-120
Authors:
Aguilar, LK
Aguilar-Cordova, E
Ando, D
Armendariz-Borunda, J
Burd, PR
Butler, EB
Carter, B
Chiang, YL
Glorioso, JC
Henderson, DR
Jolly, D
McKenny, GP
Nemunaitis, J
Rives, M
Scherer, S
Woo, SLC
Citation: Lk. Aguilar et al., A prescription for gene therapy, MOL THER, 1(5), 2000, pp. 385-388
Citation: Qp. Yao et al., Adenoviral mediated delivery of FAS ligand to arthritic joints causes extensive apoptosis in the synovial lining, J GENE MED, 2(3), 2000, pp. 210-219
Authors:
Arafat, WO
Casado, E
Wang, M
Alvarez, RD
Siegal, GP
Glorioso, JC
Curiel, DT
Gomez-Navarro, J
Citation: Wo. Arafat et al., Genetically modified CD34(+) cells exert a cytotoxic bystander effect on human endothelial and cancer cells, CLIN CANC R, 6(11), 2000, pp. 4442-4448
Authors:
Moriuchi, S
Krisky, DM
Marconi, PC
Tamura, M
Shimizu, K
Yoshimine, T
Cohen, JB
Glorioso, JC
Citation: S. Moriuchi et al., HSV vector cytotoxicity is inversely correlated with effective TK/GCV suicide gene therapy of rat gliosarcoma, GENE THER, 7(17), 2000, pp. 1483-1490
Authors:
Gomez-Navarro, J
Contreras, JL
Arafat, W
Jiang, XL
Krisky, D
Oligino, T
Marconi, P
Hubbard, B
Glorioso, JC
Curiel, DT
Thomas, JM
Citation: J. Gomez-navarro et al., Genetically modified CD34(+) cells as cellular vehicles for gene delivery into areas of angiogenesis in a rhesus model, GENE THER, 7(1), 2000, pp. 43-52
Authors:
Martino, G
Poliani, PL
Furlan, R
Marconi, P
Glorioso, JC
Adorini, L
Comi, G
Citation: G. Martino et al., Cytokine therapy in immune-mediated demyelinating diseases of the central nervous system: a novel gene therapy approach, J NEUROIMM, 107(2), 2000, pp. 184-190